Vaccinex, Inc. (VCNX)
1.06
+0.31
(+41.33%)
USD |
OTCM |
Sep 08, 16:00
Vaccinex Max Drawdown (5Y) : 99.97% for Aug. 31, 2026
Max Drawdown (5Y) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| August 31, 2026 | 99.97% |
| July 31, 2026 | 99.97% |
| June 30, 2026 | 99.97% |
| May 31, 2026 | 99.97% |
| April 30, 2026 | 99.97% |
| March 31, 2026 | 99.97% |
| February 28, 2026 | 99.97% |
| January 31, 2026 | 99.97% |
| December 31, 2025 | 99.97% |
| November 30, 2025 | 99.97% |
| October 31, 2025 | 99.97% |
| September 30, 2025 | 99.97% |
| August 31, 2025 | 99.97% |
| July 31, 2025 | 99.97% |
| June 30, 2025 | 99.97% |
| May 31, 2025 | 99.97% |
| April 30, 2025 | 99.97% |
| March 31, 2025 | 99.97% |
| February 28, 2025 | 99.95% |
| January 31, 2025 | 99.95% |
| December 31, 2024 | 99.94% |
| November 30, 2024 | 99.90% |
| October 31, 2024 | 99.90% |
| September 30, 2024 | 99.81% |
| August 31, 2024 | 99.75% |
| Date | Value |
|---|---|
| July 31, 2024 | 99.73% |
| June 30, 2024 | 99.73% |
| May 31, 2024 | 99.73% |
| April 30, 2024 | 99.73% |
| March 31, 2024 | 99.58% |
| February 29, 2024 | 99.57% |
| January 31, 2024 | 99.57% |
| December 31, 2023 | 99.57% |
| November 30, 2023 | 99.41% |
| October 31, 2023 | 99.35% |
| September 30, 2023 | 99.11% |
| August 31, 2023 | 98.17% |
| July 31, 2023 | 97.63% |
| June 30, 2023 | 97.07% |
| May 31, 2023 | 97.05% |
| April 30, 2023 | 97.05% |
| March 31, 2023 | 96.68% |
| February 28, 2023 | 96.18% |
| January 31, 2023 | 96.18% |
| December 31, 2022 | 96.18% |
| November 30, 2022 | 96.18% |
| October 31, 2022 | 95.91% |
| September 30, 2022 | 95.91% |
| August 31, 2022 | 92.55% |
| July 31, 2022 | 92.14% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 77.18% |
| Alnylam Pharmaceuticals, Inc. | 58.17% |
| Anika Therapeutics, Inc. | 83.15% |
| Savara, Inc. | 96.98% |
| Vericel Corp. | 73.97% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -81.00 |
| Beta (5Y) | 0.6713 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 94.91% |
| Historical Sharpe Ratio (5Y) | -0.7893 |
| Historical Sortino (5Y) | -1.321 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 49.44% |